false
0000899629
0000899629
2024-01-08
2024-01-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
January 8, 2024
Acadia Realty Trust
(Exact name of registrant as specified in its
charter)
Maryland |
|
1-12002 |
|
23-2715194 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification
No.) |
411
Theodore Fremd Avenue
Suite
300
Rye,
New York 10580
(Address of principal
executive offices) (Zip Code)
(914) 288-8100
(Registrant’s telephone
number, including area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Title of class of registered securities |
|
Trading symbol |
|
Name of exchange on which registered |
Common shares of beneficial interest, par value $0.001 per share |
|
AKR |
|
The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 8.01 Other Events.
On January 8, 2024, Acadia Realty Trust
(the “Company”) and its operating partnership, Acadia Realty Limited Partnership (the “Operating Partnership”),
entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and BofA Securities,
Inc. (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters 6,000,000 common shares
of beneficial interest, par value $0.001 per share (“Common Shares”). The Company also granted the Underwriters a 30-day option
to purchase up to 900,000 additional Common Shares, which was exercised in full.
The offering closed on January 11, 2024,
resulting in net proceeds to the Company of approximately $112.7 million (reflecting the exercise of the Underwriters’ option
to purchase an additional 900,000 shares), after deducting estimated offering expenses. The Company intends to use the net proceeds from
the Offering for general corporate purposes, which may include, without limitation, the repayment of outstanding indebtedness, funding
future acquisitions, working capital and other general corporate purpose activities.
The
offer and sale of the Common Shares were made pursuant to a preliminary prospectus supplement and a final prospectus supplement related
to the Company’s effective shelf registration statement on Form S-3 (File No. 333-275356), each
of which has been filed with the Securities and Exchange Commission.
The Underwriting Agreement contains customary
representations, warranties and covenants by the Company and the Operating Partnership. It also provides for customary indemnification
by the Company and the Operating Partnership for losses or damages arising out of or in connection with the sale of the Common Shares.
The foregoing is a summary description of
certain terms of the Underwriting Agreement and is qualified in its entirety by the text of the Underwriting Agreement, which is attached
as Exhibit 1.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ACADIA REALTY TRUST |
Dated: January 12, 2024 |
|
|
|
|
|
By: |
/s/ John Gottfried |
|
Name: |
John Gottfried |
|
Title: |
Executive Vice President and Chief Financial Officer |
Exhibit 1.1
Execution Version
ACADIA REALTY TRUST
6,000,000 Common Shares of Beneficial Interest
(par value $0.001 per share)
Underwriting Agreement
January 8, 2024
J.P. Morgan Securities LLC
BofA Securities, Inc.
c/o J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
c/o BofA Securities, Inc.
One Bryant Park
New York, New York 10036
Acadia
Realty Trust, a Maryland real estate investment trust (the “Company”), and Acadia Realty Limited Partnership, a Delaware
limited partnership (the “Partnership”), confirm their respective agreement to issue and sell to J.P. Morgan Securities LLC
and BofA Securities, Inc. (the “Underwriters”), an aggregate of 6,000,000 common shares of beneficial interest, par value
$0.001 per share (“Common Shares”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters,
up to an additional 900,000 Common Shares (the “Option Shares”). The Underwritten Shares and the Option Shares are herein
referred to as the “Shares”.
The Company and the Partnership
hereby confirm their agreement with each of the Underwriters concerning the purchase and sale of the Shares, as follows:
1. Registration
Statement. The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) under the
Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities
Act”), a registration statement (File No. 333-275356), including a base prospectus contained therein (the “Base Prospectus”),
relating to the Shares. Such registration statement, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C
under the Securities Act to be part of the registration statement at the time of its effectiveness (“Rule 430 Information”),
is referred to herein as the “Registration Statement”. No post-effective amendment to the Registration Statement has been
filed as of the date of this underwriting agreement (the “Underwriting Agreement”). If the Company has filed an abbreviated
registration statement pursuant to Rule 462(b) under the Securities Act (the “Rule 462 Registration Statement”),
then any reference herein to the term “Registration Statement” shall be deemed to include such Rule 462 Registration
Statement. Any preliminary prospectus relating to the Shares, including any preliminary prospectus supplement relating to the Shares filed
with the Commission, together with the Base Prospectus is herein referred to as a “Preliminary Prospectus”. “Prospectus”
means the Base Prospectus together with the final prospectus supplement filed with the Commission pursuant to and within the time limits
described in Rule 424(b) under the Securities Act. Any reference in this Underwriting Agreement to the Registration Statement,
any Preliminary Prospectus or the Prospectus, or to any amendment or supplement thereto, shall be deemed to refer to and include the filing
of any document under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder
(the “Exchange Act”), which is or is deemed to be incorporated by reference in the Registration Statement, any Preliminary
Prospectus or the Prospectus, as the case may be, and, in the case of any reference herein to the Prospectus, also shall be deemed to
include any documents incorporated by reference therein, and any supplements or amendments thereto, filed with the Commission after the
date of filing of the final prospectus supplement under Rule 424(b) under the Securities Act, and prior to the termination of
the offering of the Shares by the Underwriters. At or prior to the Applicable Time (as defined below), the Company had prepared the following
information (collectively with the pricing information set forth on Item (b) of Annex A, the “Pricing Disclosure Package”):
a Preliminary Prospectus dated January 8, 2024 and each “free-writing prospectus” (as defined pursuant to Rule 405
under the Securities Act) listed on Annex A hereto.
“Applicable Time”
means 6:30 P.M., New York City time, on January 8, 2024.
2. Purchase
of the Shares.
(a) The
Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter,
on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees,
severally and not jointly, to purchase at a price per share of $16.38 (the “Purchase Price”) from the Company the respective
number of Underwritten Shares set forth opposite such Underwriter’s name in Schedule 1 hereto.
In addition, the Company agrees
to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the
representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase,
severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or
distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares.
If any Option Shares are to
be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same
ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such
Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of Underwritten
Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional
Shares as the Underwriters in their sole discretion shall make.
The Underwriters may exercise
the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the
date of the Prospectus, by written notice from the Underwriters to the Company. Such notice shall set forth the aggregate number of Option
Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which
may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than
the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance
with the provisions of Section 10 hereof). Any such notice shall be given at least two business days prior to the date and time of
delivery specified therein.
(b) The
Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms
set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or
through any affiliate of an Underwriter.
(c) Payment
for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Underwriters
in the case of the Underwritten Shares, at the offices of Fried, Frank, Harris, Shriver & Jacobson LLP at 10:00 A.M. New
York City time on January 11, 2024, or at such other time or place on the same or such other date, not later than the fifth business
day thereafter, as the Underwriters and the Company may agree upon in writing or, in the case of the Option Shares, on the date and at
the time and place specified by the Underwriters in the written notice of the Underwriters’ election to purchase such Option Shares.
The time and date of such payment for the Underwritten Shares is referred to herein as the “Closing Date”, and the time and
date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the “Additional Closing Date”.
Payment for the Shares to
be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Underwriters
of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection
with the sale of such Shares duly paid by the Company. Delivery of the Shares shall be made through the facilities of The Depository Trust
Company (“DTC”) unless the Underwriters shall otherwise instruct. The certificates for the Shares will be made available for
inspection and packaging by the Underwriters at the office of DTC or its designated custodian not later than 1:00 P.M., New York City
time, on the business day prior to the Closing Date or the Additional Closing Date, as the case may be.
(d) The
Company and the Partnership acknowledge and agree that the Underwriters are acting solely in the capacity of an arm’s length contractual
counterparty to the Company and the Partnership with respect to the offering of Shares contemplated hereby (including in connection with
determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company, the Partnership
or any other person. Additionally, the Underwriters are not advising the Company, the Partnership or any other person as to any legal,
tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Partnership shall consult with their own advisors
concerning such matters and shall be responsible for making their own independent investigation and appraisal of the transactions contemplated
hereby, and neither of the Underwriters shall have any responsibility or liability to the Company and the Partnership with respect thereto.
Any review by the Underwriters of the Company, the Partnership, the transactions contemplated hereby or other matters relating to such
transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company or the Partnership.
3. Representations
and Warranties of the Company. Each of the Company and the Partnership, jointly and severally, represents and warrants to each Underwriter
that:
(a) Preliminary
Prospectus. No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary
Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities
Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
provided that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon
and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter expressly for use
in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of
the information described as such in Section 7(b) hereof.
(b) Pricing
Disclosure Package. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided
that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity
with information relating to any Underwriter furnished to the Company in writing by such Underwriter expressly for use in such Pricing
Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter consists of the information
described as such in Section 7(b) hereof.
(c) Issuer
Free Writing Prospectus. Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including
its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved
or referred to and will not prepare, make, use, authorize, approve or refer to any “written communication” (as defined in
Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication
by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an “Issuer Free
Writing Prospectus”) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of
the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic
road show and any other written communications approved in writing in advance by the Underwriters. Each such Issuer Free Writing Prospectus
complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed
in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information contained in the Registration
Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus filed prior to the first use of
such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will
not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation
or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in
reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter expressly
for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.
(d) Registration
Statement and Prospectus. The Registration Statement is an “automatic shelf registration statement” as defined under Rule 405
of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of
objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under
the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued
by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related
to the offering of the Shares has been initiated or threatened by the Commission; as of the applicable effective date of the Registration
Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will
comply in all material respects with the Securities Act, and did not and will not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of
the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as
the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that the Company makes no representation or warranty with respect to any statements
or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing
by such Underwriter expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto, it being
understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.
(e) Incorporated
Documents. The documents incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package,
when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such
documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and any further documents so filed with the Commission after
the date of filing of the final prospectus supplement under Rule 424(b) under the Securities Act in connection with the offering
of the Shares, and prior to the termination of the offering of the Shares by the Underwriters, and incorporated by reference in the Registration
Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material
respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(f) Financial
Statements. The Financial Statements included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing
Disclosure Package present fairly in all material respects the consolidated financial position, the results of operations and cash flows
of the Company, the Partnership and their subsidiaries as of and at the dates and for the periods specified. Such Financial Statements
comply as to form in all material respects with the applicable accounting requirements of the Securities Act, the Exchange Act, the rules and
regulations of the Commission under the Securities Act (the “Securities Act Regulations”) and the rules and regulations
of the Commission under the Exchange Act (the “Exchange Act Regulations”) and have been prepared in conformity with generally
accepted accounting principles as applied in the United States applied on a consistent basis throughout the periods involved, except as
may be expressly stated in the related notes thereto. The pro forma financial statements and other pro forma financial information, if
any, included, or incorporated by reference in, the Registration Statement, the Pricing Disclosure Package and the Prospectus include
assumptions that provide a reasonable basis for presenting the significant effects directly attributable to the transactions and events
described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect
the proper application of those adjustments to the historical financial statement amounts in the pro forma financial statements included
or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The pro forma financial
statements included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply
as to form in all material respects with the applicable accounting requirements of the Regulation S-X under the Securities Act and the
pro forma adjustments have been properly applied to the historical amounts in the compilation of those statements. No other historical,
pro forma or other financial statements or supporting schedules are required under applicable law, including the Securities Act, the Securities
Act Regulations, the Exchange Act and the Exchange Act Regulations, to be included or incorporated by reference in the Registration Statement,
the Pricing Disclosure Package and the Prospectus. The financial data included or incorporated by reference in the Registration Statement,
the Pricing Disclosure Package and the Prospectus fairly present in all material respects the information set forth therein on a basis
consistent with that of the audited financial statements contained in the Company’s most recent Annual Report on Form 10-K.
Any non-GAAP financial measures, as defined under Regulation G under the Securities Act, included or incorporated by reference in the
Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the requirements of Regulation
G and Item 10 of Regulation S-K under the Securities Act. The interactive data in eXtensible Business Reporting Language included or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly present the information called for
in all material respects and have been prepared in accordance with the Commission’s rules and guidelines applicable thereto.
(g) No
Material Adverse Change. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
subsequent to the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package and
the Prospectus: (i) there has been no material adverse change, or any development involving a prospective material adverse change,
in the condition, financial or otherwise, or in the earnings, business or operations of the Company, the Partnership and their subsidiaries,
considered as one entity (any such change, a “Material Adverse Change”); (ii) there have been no transactions entered
into by the Company, the Partnership and their subsidiaries, other than those in the ordinary course of business, which are material with
respect to the Company, the Partnership and their subsidiaries, considered as one entity; and (iii) except for regular quarterly
dividends on the Common Shares in amounts per share that are materially consistent with past practice, there has been no dividend or distribution
of any kind declared, paid or made by the Company on any class of its capital stock.
(h) Organization
and Good Standing. Each of the Company, the Partnership and their subsidiaries has been duly incorporated, formed or organized, as
the case may be, and is validly existing as a real estate investment trust, partnership, corporation, limited liability company or other
legal entity in good standing under the laws of the jurisdiction of its incorporation, organization or formation, as applicable, and has
full real estate investment trust, partnership, corporate, or other power and authority to own, lease and operate its properties and to
conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and, in the case of
the Company and the Partnership, to enter into and perform their respective obligations under this Agreement and to consummate the transactions
contemplated herein, except as would not reasonably be expected to result in a Material Adverse Change. Each of the Company, the Partnership
and each of their subsidiaries is duly qualified as a foreign corporation or other legal entity to transact business and is in good standing
in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct
of business, except for such jurisdictions where the failure to so qualify or to be in good standing would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Change. All of the issued and outstanding capital stock, membership
interests, partnership interests or similar equity interests of each subsidiary of the Company and the Partnership have been duly authorized
and validly issued, are fully paid and non-assessable, except as would not, individually or in the aggregate, reasonably be expected to
result in a Material Adverse Change. Except as otherwise set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, all equity interests in each subsidiary of the Company and the Partnership that are owned by the Company and the Partnership,
directly or through subsidiaries, are free and clear of any security interest, mortgage, pledge, lien, encumbrance or claim (collectively,
“Liens”), except for Liens, if any, securing indebtedness as described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, or except for such Liens that would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Change.
(i) Capitalization.
The authorized, issued and outstanding capital shares of the Company are as described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus (other than for subsequent issuances, if any, pursuant to this Agreement, employee benefit plans described
in the Registration Statement, the Pricing Disclosure Package and the Prospectus or upon exercise of outstanding options described in
the Registration Statement, the Pricing Disclosure Package and the Prospectus). The Common Shares (including the Shares) conform in all
material respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
All of the issued and outstanding Common Shares have been duly authorized and validly issued, are fully paid and non-assessable and have
been offered, sold and issued in compliance with federal and state securities laws. The issuance of the Shares has been duly authorized
and, upon being delivered and paid for pursuant to this Agreement, the Shares will be validly issued, fully paid and non-assessable, free
and clear of any security interest, mortgage, pledge, lien, encumbrance or claim. All of the issued and outstanding units of limited partnership
interest in the Partnership have been duly authorized by the Partnership. None of the outstanding Common Shares were issued in violation
of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company, and
the holders of the outstanding capital shares of the Company are not entitled to preemptive or other rights to subscribe for the Shares.
There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity
or debt securities convertible into or exchangeable or exercisable for, any capital shares or ownership interests in the Company other
than those described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The description of the Company’s
incentive plan and other similar plans or arrangements set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus accurately and fairly presents the information required to be shown with respect to such plans and arrangements.
(j) Due
Authorization. The Company and the Partnership have full right, power and authority to execute and deliver this Agreement and to perform
their obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by the Company
and the Partnership of this Agreement and the consummation by the Company and the Partnership of the transactions contemplated hereby
has been duly and validly taken.
(k) Underwriting
Agreement. This Agreement has been duly authorized, executed and delivered by the Company and the Partnership, respectively.
(l) The
Shares. The Shares have been duly authorized by the Company and, when issued and delivered and paid for as provided herein, will be
duly and validly issued, will be fully paid and nonassessable and will conform to the descriptions thereof in the Registration Statement,
the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights.
(m) Descriptions
of the Underwriting Agreement. This Agreement conforms in all material respects to the description thereof contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus.
(n) No
Violation or Default. Neither the Company, the Partnership nor any of the significant subsidiaries is in violation of its respective
declaration of trust, bylaws, partnership agreement, certificate of formation, charter, operating agreement or similar documents. Neither
the Company, the Partnership nor any of the significant subsidiaries is in default (or, with the giving of notice or lapse of time, would
be in default) (“Default”) under any indenture, mortgage, loan or credit agreement, note, contract, lease or other agreement,
to which the Company, the Partnership or any of the significant subsidiaries is a party or by which it or any of them may be bound, or
to which any of the property or assets of the Company, the Partnership or any of the significant subsidiaries is subject (each, an “Existing
Instrument”), except for such Defaults as would not, individually or in the aggregate, reasonably be expected to result in a Material
Adverse Change. The execution, delivery and performance of this Agreement by the Company and the Partnership, as applicable, the application
of the proceeds from the issuance of the Shares as described under “Use of Proceeds” in the Pricing Disclosure Package and
the Prospectus and the consummation of the transactions contemplated hereby and thereby and by the Registration Statement (i) will
not result in any violation of the provisions of the respective declaration of trust, bylaws, partnership agreement, certificate of formation,
charter, operating agreement or similar documents of the Company, the Partnership or any significant subsidiary, (ii) will not conflict
with or constitute a breach of, or Default under, or result in the creation or imposition of any Lien upon any property or assets of the
Company, the Partnership or any of their significant subsidiaries under any Existing Instrument, and (iii) will not result in any
violation of any law, statute, rule, regulation, judgment, order or decree, administrative regulation or administrative or court decree
applicable to the Company, the Partnership or any significant subsidiary or any of its or their property, except, in the case of clauses
(ii) and (iii) above as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Change.
(o) No
Consents Required. No consent, approval, authorization or other order of, or registration or filing with, any court or other governmental
or regulatory authority or agency, is required for the Company’s or the Partnership’s execution, delivery and performance
of this Agreement and consummation of the transactions contemplated hereby and thereby and by the Registration Statement, the Prospectus
and the Pricing Disclosure Package, except such consents, approvals, authorizations, orders, filings, registrations or qualifications
as may be required under applicable state securities or Blue Sky laws and from the Financial Industry Regulatory Authority, Inc.
(“FINRA”).
(p) Legal
Proceedings. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no legal or governmental actions, suits, investigations or proceedings involving the Company, the Partnership or any of their subsidiaries
pending or, to the best of the Company’s or the Partnership’s knowledge, threatened that would reasonably be expected to result
in a Material Adverse Change or have a material adverse effect the consummation of the transactions contemplated by this Agreement. No
labor dispute with the employees of the Company, the Partnership or any of their subsidiaries exists or, to the best of the Company’s
and the Partnership’s knowledge, is threatened that would reasonably be expected to result in a Material Adverse Change.
(q) Independent
Accountants. (a) BDO USA, P.C., which delivered its audit report with respect to the consolidated financial statements of the
Company, including the related notes and schedules, if any, thereto (collectively, the “Financial Statements”), filed with
the Commission and included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
is an independent registered public accounting firm as required by the Securities Act, the Exchange Act and the rules and regulations
of the Public Company Accounting Oversight Board (the “PCAOB”), and (b) Deloitte & Touche LLP, is an independent
registered public accounting firm as required by the Securities Act, the Exchange Act and the rules and regulations of the PCAOB.
(r) Title
to Real and Personal Property. Each of the Company, the Partnership and each of their subsidiaries owns or leases all such properties
as are necessary to the conduct of their respective operations as presently conducted, except as would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Change. The Company, the Partnership and each of their subsidiaries has good and
marketable title to all the properties and assets reflected as owned in the Company’s consolidated financial statements (and schedules
thereto) or elsewhere in the Registration Statement, the Pricing Disclosure Package and the Prospectus, in each case free and clear of
any security interests, mortgages, liens, encumbrances, equities, claims and other defects, except as disclosed in the Registration Statement,
the Pricing Disclosure Package and the Prospectus or where the existence of any security interest, mortgage, lien, encumbrance, equity,
claim or other defect would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change. The
real property, improvements, equipment and personal property held under lease by the Company, the Partnership or any of their subsidiaries
are held under valid and enforceable leases, except as disclosed in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, or where the invalidity or unenforceability of any leases would not, individually or in the aggregate, reasonably be expected
to result in a Material Adverse Change.
(s) Intellectual
Property. The Company, the Partnership and their subsidiaries own or possess sufficient trademarks, trade names, patent rights, copyrights,
domain names, licenses, approvals, trade secrets and other similar rights (collectively, “Intellectual Property Rights”) reasonably
necessary to conduct their businesses as now conducted or as proposed to be conducted in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, except for such Intellectual Property Rights the absence of which would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Change. Except as set forth in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, neither the Company, the Partnership, nor any of their subsidiaries has received any notice of infringement
or conflict with asserted Intellectual Property Rights of others, which infringement or conflict, if the subject of an unfavorable decision,
would reasonably be expected to result in a Material Adverse Change. The Company and the Partnership are not parties to or bound by any
options, licenses or agreements with respect to the Intellectual Property Rights of any other person or entity that are required to be
set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus and are not described in all material respects.
None of the technology employed by the Company or the Partnership has been obtained or is being used by the Company or the Partnership
in violation of any contractual obligation binding on the Company, the Partnership or, to the Company’s or the Partnership’s
knowledge, any of their officers, trustees or employees or is otherwise in violation of the rights of any persons, except for violations
which would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change.
(t) No
Undisclosed Relationships. There are no business relationships or related-party transactions involving the Company, the Partnership
or any subsidiary of either or any other person required to be described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus that have not been described as required.
(u) Investment
Company Act. Each of the Company and the Partnership is not, and after giving effect to the offer and sale of the Shares, as applicable,
and after receipt of payment for the Shares on the Closing Date and on the Additional Closing Date, as the case may be, and the application
of the proceeds therefrom as described under “Use of Proceeds” in each of the Registration Statement, the Pricing Disclosure
Package and the Prospectus will not be, required to be registered as, an “investment company” or a company “controlled”
by an “investment company” within the meaning of the Investment Company Act of 1940, as amended.
(v) Taxes.
The Company, the Partnership and their subsidiaries (i) have filed all material federal, state, local and foreign income and
franchise tax returns required to be filed by such entities or have properly requested extensions thereof, and (ii) have paid all
material taxes required to be paid by any of them and, if due and payable, any related or similar assessment, fine or penalty levied
against any of them, except in the case of each of (i) and (ii), to the extent they have been or are being contested in good faith
and by appropriate proceedings, as would not reasonably be expected to result in a Material Adverse Change or as set forth in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. To the knowledge of the Company, there is no tax deficiency likely to be
asserted against the Company, the Partnership or any of their subsidiaries that would reasonably be expected to result in a Material
Adverse Change. All material tax liabilities, if any, of the Company, the Partnership and their subsidiaries are adequately provided
for on the respective books of the entities.
(w) Licenses
and Permits. The Company, the Partnership and each subsidiary possess such valid and current certificates, authorizations, licenses
or permits issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their respective businesses,
except where the failure to possess such certificates, authorizations, licenses or permits would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Change, and neither the Company, the Partnership nor any of their subsidiaries
has received any notice of proceedings relating to the revocation or modification of, or non-compliance with, any such certificate, authorization,
license or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be
expected to result in a Material Adverse Change, except as set forth in the Registration Statement, the Pricing Disclosure Package and
the Prospectus.
(x) REIT
Qualification. The Company has met the requirements for qualification and taxation as a real estate investment trust (“REIT”)
under the Internal Revenue Code of 1986, as amended (the “Code”), as of the close of every taxable year during the Company’s
existence, and the Company’s current and proposed method of operation will enable it to continue to meet the requirements for qualification
and taxation as a real estate investment trust for federal income tax purposes.
(y) Qualification
of Partnership and Subsidiaries. Each of the Partnership and any limited liability company or partnership subsidiary, except for any
such subsidiaries that have elected to be treated as taxable REIT subsidiaries, is qualified as a partnership or a disregarded entity
for federal income tax purposes and not as an association taxable as a corporation or as a publicly traded partnership.
(z) Certain
Environmental Matters. Except (x) as otherwise described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus or (y) as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change:
(i) neither the Company, the Partnership, nor any of their subsidiaries is in violation of any federal, state, local or foreign law
or regulation relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface
water, groundwater, land surface or subsurface strata) or wildlife, including without limitation, laws and regulations relating to emissions,
discharges, releases or threatened releases of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
and petroleum products (collectively, “Materials of Environmental Concern”), or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Materials of Environmental Concern (collectively, “Environmental
Laws”), which violation includes, but is not limited to, noncompliance with any permits or other governmental authorizations required
for the operation of the business of the Company, the Partnership or their subsidiaries under applicable Environmental Laws, or noncompliance
with the terms and conditions thereof, nor has the Company, the Partnership or any of their subsidiaries received any written communication,
whether from a governmental authority, citizens group, employee or otherwise, that alleges that the Company, the Partnership or any of
their subsidiaries is in violation of any Environmental Law; (ii) there is no claim, action or cause of action filed with a court
or governmental authority, no investigation with respect to which the Company or the Partnership has received written notice, and no written
notice by any person or entity alleging potential liability for investigatory costs, cleanup costs, governmental responses costs, natural
resources damages, property damages, personal injuries, attorneys’ fees or penalties arising out of, based on or resulting from
the presence, or release into the environment, of any Materials of Environmental Concern at any location owned, leased or operated by
the Company, the Partnership or any of their subsidiaries, now or in the past (collectively, “Environmental Claims”), pending
or, to the best of the Company’s and the Partnership’s knowledge, threatened against the Company, the Partnership or any of
their subsidiaries or any person or entity whose liability for any Environmental Claim the Company, the Partnership or any of their subsidiaries
has retained or assumed either contractually or by operation of law; and (iii) to the Company’s and the Partnership’s
knowledge, there are no past or present actions, activities, circumstances, conditions, events or incidents, including, without limitation,
the release, emission, discharge, presence or disposal of any Materials of Environmental Concern, that reasonably could result in a violation
of any Environmental Law or form the basis of a potential Environmental Claim against the Company, the Partnership or any of their subsidiaries
or against any person or entity whose liability for any Environmental Claim the Company, the Partnership, or any of their subsidiaries
has retained or assumed either contractually or by operation of law. Except as set forth in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, neither the Company, the Partnership nor any subsidiary has been named as a “potentially responsible
party” under the Comprehensive Environmental Responses Compensation and Liability Act of 1980, as amended.
(aa) Compliance
with ERISA. The Company, the Partnership and their subsidiaries and any “Employee Benefit Plan” (as defined under the
Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively,
“ERISA”)) established or maintained by the Company, the Partnership and their subsidiaries or their ERISA Affiliates (as defined
in this Section 1(aa)) are in compliance in all material respects with ERISA. “ERISA Affiliate” means, with respect to
the Company, the Partnership or a subsidiary, any member of any group of organizations described in Sections 414(b), (c), (m) or
(o) of the Code, of which the Company, the Partnership or such subsidiary is a member. No “reportable event” (as defined
under ERISA) has occurred or is reasonably expected to occur with respect to any Employee Benefit Plan established or maintained by the
Company, the Partnership, their subsidiaries or any of their ERISA Affiliates. No Employee Benefit Plan established or maintained by the
Company, the Partnership, their subsidiaries or any of their ERISA Affiliates, if such Employee Benefit Plan were terminated, would have
any “amount of unfunded benefit liabilities” (as defined under ERISA). Neither the Company, the Partnership, their subsidiaries
nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i) Title IV of ERISA with respect
to termination of, or withdrawal from, any Employee Benefit Plan or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each Employee
Benefit Plan established or maintained by the Company, the Partnership, their subsidiaries or any of their ERISA Affiliates that is intended
to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or failure to act,
which would cause the loss of such qualification.
(bb) Controls.
The Company has established and maintains, on a consolidated basis, disclosure controls and procedures (as such term is defined in Rules 13a-15
and 15d-15 under the Exchange Act Regulations); such disclosure controls and procedures are designed to ensure that the information required
to be disclosed by the Company in the reports it files or submits under the Exchange Act is accumulated and communicated to management
of the Company and its subsidiaries, including their respective principal executive officers and principal financial officers, as appropriate,
to allow timely decisions regarding required disclosure to be made; and such disclosure controls and procedures are effective in all
material respects to perform the functions for which they were established. Except as otherwise described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal year, (i) the
Company has not been advised of (A) any material weaknesses in the design or operation of internal controls that would adversely
affect the ability of the Company or any of its subsidiaries to record, process, summarize and report financial data, or any material
weaknesses in internal controls or (B) any fraud, whether or not material, that involves management or other employees who have
a significant role in the internal controls of the Company and each of its subsidiaries, and (ii) there have been no changes in
internal controls or in other factors that materially affected, or are reasonably likely to materially affect, internal controls, including
any corrective actions with regard to significant deficiencies and material weaknesses. The Company, the Partnership and their subsidiaries,
on a consolidated basis, maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions
are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally accepted accounting principles as applied in the United States
and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general
or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.
(cc) Insurance.
Each of the Company, the Partnership and their subsidiaries are insured by recognized, financially sound and reputable institutions
with policies in such amounts and with such deductibles and covering such risks as are prudent and customary for their respective businesses
including, but not limited to, policies covering real and personal property owned or leased by the Company, the Partnership and their
subsidiaries against theft, damage, destruction, acts of vandalism and all other risks customarily insured against, except where the failure
to be so insured would not reasonably be expected to result in a Material Adverse Change. All such policies of insurance are in full force
and effect, except as would not reasonably be expected to result in a Material Adverse Change. There are no claims by the Company, the
Partnership or any of their subsidiaries under any such policy or instrument as to which any insurance company is denying liability or
defending under a reservation of rights clause, except where such denial or defense would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Change. Neither the Company, the Partnership nor any subsidiary has been refused insurance
coverage sought or applied for and neither the Company, the Partnership nor any subsidiary has reason to believe that it or any subsidiary
will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable
coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted, in each case, at a cost
that would not reasonably be expected to result in a Material Adverse Change, or except as set forth in or contemplated by the Registration
Statement, the Pricing Disclosure Package and the Prospectus.
(dd) Cybersecurity;
Data Protection. (A) To the knowledge of the Company and the Partnership, there has been no security breach or incident, unauthorized
access or disclosure, or other compromise of or relating to the Company’s, the Partnership’s or their subsidiaries’
information technology and computer systems, networks, hardware, software, data and databases (including the data and information of
their respective customers, employees, suppliers, vendors and any third party data maintained, processed or stored by the Company, the
Partnership and their subsidiaries, and any such data processed or stored by third parties on behalf of the Company, the Partnership
and their subsidiaries), equipment or technology (collectively, “IT Systems and Data”): (B) none of the Company, the
Partnership nor their subsidiaries have been notified of, and have no knowledge of any event or condition that would reasonably be expected
to result in, any security breach or incident, unauthorized access or disclosure or other compromise to their IT Systems and Data and
(C) the Company, the Partnership and their subsidiaries have implemented appropriate controls, policies, procedures, and technological
safeguards to maintain and protect the integrity, continuous operation, redundancy and security of their IT Systems and Data reasonably
consistent with industry standards and practices, or as required by applicable regulatory standards, except as would not, in the case
of each of (A) through (C), reasonably be expected to result in a Material Adverse Change with respect to the Company, the Partnership
and their subsidiaries, considered as one entity. The Company, the Partnership and their subsidiaries are presently in material compliance
with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental
or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and
to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification.
(ee) No
Unlawful Payments. Neither the Company, the Partnership nor any of their subsidiaries nor, to the knowledge of the Company or the
Partnership, any trustee, officer, agent, employee or affiliate of the Company, the Partnership or any of their subsidiaries is aware
of or has taken any action, directly or indirectly, that would result in a violation of such persons of the Foreign Corrupt Practices
Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), including, without limitation, making
use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay
or authorization of the payment of any money, or other property, gift, promise to give or authorization of the giving of anything of value
to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any
candidate for foreign political office, in contravention of the FCPA and the Company, the Partnership, their subsidiaries and, to the
knowledge of the Company and the Partnership, their affiliates have conducted their businesses in compliance with the FCPA and have instituted
and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith.
(ff) Compliance
with Anti-Money Laundering Laws. The operations of the Company, the Partnership and their subsidiaries are and have been conducted
at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money
Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company, the Partnership or any of their subsidiaries with respect to the Money Laundering Laws is pending or, to the best
knowledge of the Company or the Partnership threatened.
(gg) No
Conflicts with Sanctions Laws. Neither the Company, the Partnership nor any of their subsidiaries nor, to the knowledge of the Company,
the Partnership, any trustee, officer, agent, employee or affiliate of the Company or the Partnership or any of their subsidiaries is
currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.
(hh) Limited
Partnership Agreement. The limited partnership agreement of the Partnership, including any amendments thereto has been duly and validly
authorized, executed and delivered by the Company and, to the best knowledge of the Company, all the partners of the Partnership and
constitutes a valid and binding agreement, enforceable in accordance with its terms, except as may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally or by general principles of equity.
(ii) No
Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends
to the Company, from making any other distribution on such subsidiary’s capital stock, from repaying to the Company any loans or
advances to such subsidiary from the Company or from transferring any of such subsidiary’s property or assets to the Company or
any other subsidiary of the Company, except as would not reasonably be expected to result in a Material Adverse Change or as described
in or contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus.
(jj) No
Broker’s Fees. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is
no broker, finder or other party that is entitled to receive from the Company or the Partnership, any brokerage or finder’s fee
or other fee or commission as a result of any transactions contemplated by this Agreement.
(kk) No
Registration Rights. No person has the right to require the Company or any of its subsidiaries to register any securities for sale
under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Shares.
(ll) No
Stabilization. The Company and the Partnership have not taken and will not take, directly or indirectly, any action designed to or
that might be reasonably expected to cause or result in, or which has constituted or which might reasonably be expected to constitute,
the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.
(mm) Margin
Rules. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described
in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board
of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
(nn) Statistical
and Market Data. Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and
market-related data included or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the
Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.
(oo) Sarbanes-Oxley
Act. There is and has been no failure on the part of the Company and any of the Company’s trustees or officers, in their capacities
as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith
(the “Sarbanes-Oxley Act”), including Section 402 of the Sarbanes-Oxley Act related to loans and Sections 302 and 906
thereof related to certifications.
(pp) Status
under the Securities Act. (A) At the original effectiveness of the Registration Statement, (B) at the earliest time after
the original effectiveness of the Registration Statement that the Company or another offering participant made a bona fide offer (within
the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Shares, and (C) as of the date of the execution
and delivery of this Agreement (with such date being used as the determination date for purposes of this clause), the Company was not
and is not an “ineligible issuer,” and is a well-known seasoned issuer, in each case as defined in Rule 405 under the
Securities Act, without taking account of any determination by the Commission pursuant to Rule 405 under the Securities Act Regulations
that it is not necessary that the Company be considered an ineligible issuer.
(qq) No
Ratings. There are (and prior to the Closing Date, will be) no outstanding debt securities, convertible securities or preferred stock
issued or guaranteed by the Company or the Partnership that are rated by a “nationally recognized statistical rating organization”,
as such term is defined in Section 3(a)(62) under the Exchange Act.
4. Further
Agreements of the Company. The Company covenants and agrees with each Underwriter that:
(a) Required
Filings. The Company will file: (i) the Prospectus with the Commission within the time periods specified by Rule 424(b) and
Rule 430A, 430B or 430C under the Securities Act, (ii) any Issuer Free Writing Prospectus to the extent required by Rule 433
under the Securities Act; and (iii) promptly all reports and any definitive proxy or information statements required to be filed
by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date
of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares; and
the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to
the Underwriters in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement
in such quantities as the Underwriters may reasonably request. The Company will pay the registration fee for this offering within the
time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein) and in any event
prior to the Closing Date.
(b) Delivery
of Copies. The Company will deliver, without charge, (i) to the Underwriters three signed copies of the Registration Statement
as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated
by reference therein; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and
each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies of the
Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing
Prospectus) as the Underwriter may reasonably request. As used herein, the term “Prospectus Delivery Period” means such period
of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating
to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection
with sales of the Shares by any Underwriter or dealer.
(c) Amendments
or Supplements, Issuer Free Writing Prospectuses. Before making, preparing, using, authorizing, approving, referring to or filing
any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure
Package or the Prospectus, the Company will furnish to the Underwriters and counsel for the Underwriters a copy of the proposed Issuer
Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any
such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which any Underwriter reasonably objects.
(d) Notice
to the Underwriters. The Company will advise the Underwriters promptly, and confirm such advice in writing, (i) when any amendment
to the Registration Statement has been filed or becomes effective; (ii) when any supplement to the Pricing Disclosure Package, the
Prospectus, or any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iii) of any
request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt
of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information;
(iv) of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness
of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package,
or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities
Act; (v) of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus,
any of the Pricing Disclosure Package, or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing when the Prospectus, the Pricing Disclosure Package, or any such Issuer Free Writing Prospectus is delivered to a purchaser,
not misleading; (vi) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement
or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (vii) of the receipt by
the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or
the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary
Prospectus, any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of the Shares and, if any such
order is issued, will obtain as soon as possible the withdrawal thereof.
(e) Ongoing
Compliance. (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist
as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus
is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with law, the
Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the
Commission and furnish to the Underwriters and to such dealers as the Underwriters may designate such amendments or supplements to the
Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements
in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein)
will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus
will comply with law and (2) if at any time prior to the Closing Date (i) any event or development shall occur or condition
shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement
the Pricing Disclosure Package to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare
and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such
dealers as the Underwriters may designate such amendments or supplements to the Pricing Disclosure Package (or any document to be filed
with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package
as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to
a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law.
(f) Blue
Sky Compliance. The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Underwriters shall reasonably request and will continue such qualifications in effect so long as required for distribution of the
Shares; provided that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer
in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service
of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.
(g) Earning
Statement. The Company will make generally available to its security holders and the Underwriters as soon as practicable an earning
statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated
thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the “effective
date” (as defined in Rule 158) of the Registration Statement, which obligation may be satisfied by filing such earnings statement
or statements with the Commission’s Electronic Data Gathering, Analysis and Retrieval system (“EDGAR”).
(h) Clear
Market. For a period of 45 days (“Lock-up Period”) after the date of the Prospectus, the Company will not (i) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission
a registration statement under the Securities Act relating to, any Common Shares or any securities convertible into or exercisable or
exchangeable for Common Shares, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap
or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Shares or any such
other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common
Shares or such other securities, in cash or otherwise, without the prior written consent of the Underwriters, other than the Shares to
be sold hereunder.
The restrictions described
above do not apply to (i) the filing of a prospectus supplement with the Commission under Rule 424(b) in connection with
the Company’s at-the-market program (it being understood that the Company shall not be permitted to make any sales under such at-the-market
program during the Lock-up Period), (ii) the issuance of Common Shares or securities convertible into or exercisable for Common Shares
pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net
exercise) or the settlement of restricted stock units (“RSUs”) (including net settlement), in each case outstanding on the
date of this Agreement and described in the Prospectus; (iii) grants of options, share appreciation rights, restricted shares, RSUs,
unrestricted shares, dividend equivalent rights, common units of limited partnership interest in the Partnership (“OP Units”)
granted as long-term incentive compensation, or other equity awards and the issuance of Common Shares or securities convertible into or
exercisable or exchangeable for Common Shares (whether upon the exercise of stock options or otherwise) pursuant to the terms of an equity
compensation plan in effect as of the Closing Date and described in the Prospectus (each such plan, an “Incentive Plan”);
(iv) the filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan
in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar
strategic transaction, (v) Common Shares issuable upon the exchange of common and preferred OP Units, and (vi) Common Shares
in respect of tax withholding payments due upon the exercise of options or the vesting of restricted stock grants pursuant to any Incentive
Plan.
(i) Use
of Proceeds. The Company and the Partnership will apply the net proceeds from the sale of the Shares as described in each of the Registration
Statement, the Pricing Disclosure Package and the Prospectus under the heading “Use of Proceeds”.
(j) No
Stabilization. Neither the Company nor its subsidiaries or affiliates will take, directly or indirectly, any action designed to or
that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Common Shares.
(k) Exchange
Listing. The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on the New York Stock
Exchange (the “Exchange”).
(l) Reports.
So long as the Shares are outstanding, the Company will furnish to the Underwriters, as soon as they are available, copies of all reports
or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished
to or filed with the Commission or any national securities exchange or automatic quotation system; provided the Company will be
deemed to have furnished such reports and financial statements to the Underwriters to the extent they are filed on EDGAR.
(m) Record
Retention. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.
5. Certain
Agreements of the Underwriters. Each Underwriter hereby represents and agrees that:
(a) It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any “free writing prospectus”,
as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by
the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than
(i) a free writing prospectus that contains no “issuer information” (as defined in Rule 433(h)(2) under the
Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed
Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or
Section 4(c) above (including any electronic road show), or (iii) any free writing prospectus prepared by such underwriter
and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an “Underwriter
Free Writing Prospectus”).
(b) It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms
of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission.
(c) It
is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify
the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).
6. Conditions
of Underwriters’ Obligations. The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or
the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company
of its covenants and other obligations hereunder and to the following additional conditions:
(a) Registration
Compliance; No Stop Order. No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before
or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission
under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities
Act) and in accordance with Section 4(a) hereof; and all requests by the Commission for additional information shall have been
complied with to the reasonable satisfaction of the Underwriters.
(b) Representations
and Warranties. The representations and warranties of the Company and the Partnership contained herein shall be true and correct on
the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company
and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date
or the Additional Closing Date, as the case may be.
(c) No
Material Adverse Change. No event or condition of a type described in Section 3(g) hereof shall have occurred or shall exist,
which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus
(excluding any amendment or supplement thereto) and the effect of which in the judgment of the Underwriters makes it impracticable or
inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case
may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
(d) Officer’s
Certificate. The Underwriters shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be,
a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of
the Company who is satisfactory to the Underwriters (i) confirming that such officers have carefully reviewed the Registration Statement,
the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in Sections 3(b) and
3(d) hereof are true and correct, (ii) confirming that the other representations and warranties of the Company and the Partnership
in this Agreement are true and correct and that the Company and the Partnership have complied with all agreements and satisfied all conditions
on their part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be,
and (iii) to the effect set forth in paragraphs (a), (b) and (c) above.
(e) Comfort
Letters. On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, BDO USA, P.C. and
Deloitte & Touche LLP shall have furnished to the Underwriters, at the request of the Company, letters, dated the respective
dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Underwriters, containing
statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect
to the financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date,
as the case may be, shall use a “cut-off” date no more than two business days prior to such Closing Date or such Additional
Closing Date, as the case may be.
(f) Opinion
and 10b-5 Statement of Counsel for the Company. Goodwin Procter LLP, counsel for the Company, shall have furnished to the Underwriters,
at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the Additional Closing Date, as the
case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Underwriters.
(g) Opinion
of General Counsel for the Company. Jason Blacksberg, Esq., Chief Legal Officer for the Company, shall have furnished to the
Underwriters, his written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters,
in form and substance reasonably satisfactory to the Underwriters.
(h) Opinion
of Tax Counsel for the Company. Seyfarth Shaw LLP, tax counsel for the Company, shall have furnished to the Underwriters, at the request
of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Underwriters.
(i) Opinion
of Maryland Counsel for the Company. Venable LLP, Maryland counsel for the Company, shall have furnished to the Underwriters, at the
request of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed
to the Underwriters, in form and substance reasonably satisfactory to the Underwriters.
(j) Opinion
and 10b-5 Statement of Counsel for the Underwriters. The Underwriters shall have received on and as of the Closing Date or the Additional
Closing Date, as the case may be, an opinion and 10b-5 statement, addressed to the Underwriters, of Fried, Frank, Harris, Shriver &
Jacobson LLP, counsel for the Underwriters, with respect to such matters as the Underwriters may reasonably request, and such counsel
shall have received such documents and information as they may reasonably request to enable them to pass upon such matters.
(k) No
Legal Impediment to Issuance and Sale. No action shall have been taken and no statute, rule, regulation or order shall have been enacted,
adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional
Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order of any federal, state or foreign
court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance
or sale of the Shares.
(l) Good
Standing. The Underwriters shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory
evidence of the good standing of the Company and the Partnership in their respective jurisdictions of organization, in each case in writing
or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.
(m) Exchange
Listing. The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved
for listing on the Exchange, subject to official notice of issuance.
(n) Lock-up
Agreements. The “lock-up” agreements, each substantially in the form of Exhibit A hereto, executed by certain
officers and trustees of the Company listed on Exhibit B hereto relating to sales and certain other dispositions of Common
Shares or certain other securities, delivered to the Underwriters on or before the date hereof, shall be full force and effect on the
Closing Date or the Additional Closing Date, as the case may be.
(o) Additional
Documents. On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to
the Underwriters such further certificates and documents as the Underwriters may reasonably request.
All opinions, letters, certificates
and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they
are in form and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnification
and Contribution.
(a) Indemnification
of the Underwriters. The Company and the Partnership, jointly and severally agree to indemnify and hold harmless each Underwriter,
its affiliates (as such term is defined in Rule 501(b) of the Securities Act Regulations), directors and officers and each person,
if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
and the successors and assigns of all of the foregoing persons from and against any and all losses, claims, damages and liabilities (including,
without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as
such fees and expenses are incurred), that any of the foregoing persons may incur under the Securities Act, the Exchange Act, federal
or state statutory law or regulation, the common law, or otherwise, insofar as such loss, claim, damage, clam or liability arises out
of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement
or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to
make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained
in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any “issuer
information” filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any road show as defined
in Rule 433(h) under the Securities Act (a “road show”) or any Pricing Disclosure Package (including any Pricing
Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case
except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the
Company in writing by such Underwriter expressly for use therein, it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in paragraph (b) below.
(b) Indemnification
of the Company and the Partnership. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company
and the Partnership, and, as applicable, their trustees, officers who signed the Registration Statement and each person, if any, who controls
the Company and the Partnership within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to
the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities
that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and
in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter expressly for
use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been
amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information
in the Prospectus furnished on behalf of each Underwriter: the information contained in the twelfth and thirteenth paragraphs under the
caption “Underwriting”.
(c) Notice
and Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section 7, such person (the “Indemnified Person”) shall promptly notify the person against whom such indemnification
may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall
not relieve it from any liability that it may have under the preceding paragraphs of this Section 7 except to the extent that it
has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise
than under the preceding paragraphs of this Section 7. If any such proceeding shall be brought or asserted against an Indemnified
Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory
to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent
the Indemnified Person and any others entitled to indemnification pursuant to this Section 7 that the Indemnifying Person may designate
in such proceeding and shall pay the fees and expenses in such proceeding and shall pay the fees and expenses of such counsel related
to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified
Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be
legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the
named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person
and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them.
It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified
Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter,
its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Underwriters
and any such separate firm for the Company, the Partnership, and, as applicable, their trustees, officers who signed the Registration
Statement and any control persons of the Company and the Partnership shall be designated in writing by the Company and the Partnership,
respectively. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but
if settled with such consent, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability
by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an
Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying
Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered
into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed
the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the
written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified
Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement
(x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified
Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to
or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.
(d) Contribution.
If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or insufficient in
respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu
of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result
of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received
by the Company and the Partnership, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if
the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only
the relative benefits referred to in clause (i) but also the relative fault of the Company and the Partnership, on the one hand,
and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities,
as well as any other relevant equitable considerations. The relative benefits received by the Company and the Partnership, on the one
hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting
expenses) received by the Company from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters
in connection therewith, in each case as set forth in the table on the cover of the Prospectus, or the fee to be received by bear to the
aggregate offering price of the Shares. The relative fault of the Company and the Partnership, on the one hand, and the Underwriters on
the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Partnership or by the
Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement
or omission.
(e) Limitation
on Liability. The Company, the Partnership and the Underwriters agree that it would not be just and equitable if contribution pursuant
to paragraph (d) above were determined by pro rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above.
The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph
(d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified
Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d) and (e), in no event shall an
Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received
by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. The Underwriters’ obligations to contribute pursuant to paragraphs (d) and (e) are
several in proportion to their respective purchase obligations hereunder and not joint.
(f) Non-Exclusive
Remedies. The remedies provided for in this Section 7 paragraphs (a) through (e) are not exclusive and shall not limit
any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity.
8. Effectiveness
of Agreement. This Agreement shall become effective as of the date first written above.
9. Termination.
This Agreement may be terminated in the absolute discretion of the Underwriters, by notice to the Company, if after the execution and
delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date
(i) trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock
Market; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter
market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities;
or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or
crisis, either within or outside the United States, that, in the judgment of the Underwriters, is material and adverse and makes it impracticable
or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the
case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.
10. Defaulting
Underwriter.
(a) If,
on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Shares
that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase
of such Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such
default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase
such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting
Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business
days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in
the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any
amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the
term “Underwriter” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed
in Schedule 1 hereto that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to purchase.
(b) If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing
Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to be purchased
on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of Shares that such
Underwriter agreed to purchase hereunder on such date plus such Underwriter’s pro rata share (based on the number of Shares that
such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements
have not been made.
(c) If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing
Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased on such
date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect to any
Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall
terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 10
shall be without liability on the part of the Company or the Partnership, except that the Company will continue to be liable for the payment
of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall
remain in effect.
(d) Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter
for damages caused by its default.
11. Payment
of Expenses.
(a) Whether
or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause
to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the
costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable in that connection;
(ii) the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary
Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments
and supplements thereto) and the distribution thereof; (iii) the fees and expenses of the Company’s counsel and independent
accountants; (iv) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility
for investment of the Shares under the laws of such jurisdictions as the Underwriters may designate and the preparation, printing and
distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriters); (v) the cost
of preparing stock certificates; (vi) the costs and charges of any transfer agent and any registrar; (vii) all expenses and
application fees incurred in connection with any filing with, and clearance of the offering by, FINRA; (viii) all expenses incurred
by the Company in connection with any “road show” presentation to potential investors; and (ix) all expenses and application
fees related to the listing of the Shares on the Exchange.
(b) Except
as otherwise set forth herein, the Company shall not be required to pay for any of the Underwriters’ expenses, except that if (i) this
Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Shares for delivery to the
Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company
agrees to reimburse the Underwriters for all reasonable and documented out-of-pocket costs and expenses (including the fees and expenses
of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby.
12. Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers, trustees and directors and any controlling persons referred to herein, and the affiliates of each Underwriter
referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or
equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from
any Underwriter shall be deemed to be a successor merely by reason of such purchase.
13. Survival.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company, the Partnership and the
Underwriters contained in this Agreement or made by or on behalf of the Company, the Partnership or the Underwriters pursuant to this
Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full
force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company, the Partnership
or the Underwriters or the directors, trustees, officers, controlling persons or affiliates referred to in Section 7 hereof.
14. Certain
Defined Terms. For purposes of this Agreement, (a) except where otherwise expressly provided, the term “affiliate”
has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other
than a day on which banks are permitted or required to be closed in New York City; (c) the term “subsidiary” has the
meaning set forth in Rule 405 under the Securities Act; and (d) the term “significant subsidiary” has the meaning
set forth in Rule 1-02 of Regulation S-X under the Exchange Act.
15. Compliance
with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26,
2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the
Company, which information may include the name and address of their respective clients, as well as other information that will allow
the Underwriters to properly identify their respective clients.
16. Miscellaneous.
(a) Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Underwriters c/o J.P. Morgan
Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: (212) 622-8358); Attention Equity Syndicate Desk and c/o BofA Securities, Inc.,
One Bryant Park, New York, New York 10036, Email: dg.ecm_execution_services@bofa.com, Attention: Syndicate Department, with a copy to:
Email: dg.ecm_legal@bofa.com Attention: ECM Legal. Notices to the Company and the Partnership shall be given to them at 411 Theodore Fremd
Avenue, Suite 300, Rye, New York 10580, Facsimile: 914-288-2138, Attention: Chief Legal Officer.
(b) Governing
Law. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York.
(c) Submission
to Jurisdiction. The Company, the Partnership and the Underwriters hereby submit to the exclusive jurisdiction of the U.S. federal
and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to
this Agreement or the transactions contemplated hereby. Each of the Company, the Partnership and the Underwriters waives any objection
which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the Company, the Partnership
and the Underwriters agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding
upon the Company, the Partnership and the Underwriters, as applicable, and may be enforced in any court to the jurisdiction of which Company,
the Partnership and the Underwriters are subject by a suit upon such judgment.
(d) Waiver
of Jury Trial. Each of the parties hereto hereby waives any right to trial by jury in any suit
or proceeding arising out of or relating to this Agreement.
(e) Recognition
of the U.S. Special Resolution Regimes.
(i) In the
event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.
(ii) In the
event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a
U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be
exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.
As used in this Section 16(e):
“BHC Act Affiliate”
has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).
“Covered Entity”
means any of the following:
(i) a “covered
entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii) a “covered
bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(iii) a “covered
FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Default Right”
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as
applicable.
“U.S. Special
Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title
II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
(f) Counterparts.
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument.
(g) Amendments
or Waivers. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.
(h) Headings.
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement.
[Signature pages follow.]
If
the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided
below.
|
Very
truly yours, |
|
|
|
ACADIA
REALTY TRUST |
|
|
|
By: |
/s/
Jason Blacksberg |
|
|
Name: |
Jason Blacksberg |
|
|
Title: |
Executive Vice President and Chief
Legal Officer |
|
|
|
ACADIA
REALTY LIMITED PARTNERSHIP |
|
|
|
By: |
ACADIA
REALTY TRUST |
|
|
Its
sole general partner |
|
|
|
By: |
/s/
Jason Blacksberg |
|
|
Name: |
Jason Blacksberg |
|
|
Title: |
Executive Vice President and Chief
Legal Officer |
|
|
Accepted:
As of the date first written above |
|
|
|
J.P.
MORGAN SECURITIES LLC |
|
|
|
By: |
/s/
Haley Trethaway |
|
Authorized
Signatory |
|
|
|
BOFA
SECURITIES, INC. |
|
|
|
By: |
/s/
Hicham Hamdouch |
|
Authorized
Signatory |
|
Schedule
1
Underwriter | |
Number
of Shares | |
J.P.
Morgan Securities LLC | |
| 3,000,000 | |
BofA
Securities, Inc. | |
| 3,000,000 | |
Total | |
| 6,000,000 | |
ANNEX
A
| a. | Pricing Disclosure Package |
None.
| b. | Pricing Information Provided Orally by Underwriters |
The public offering price per share: Variable
price offering on an investor-by-investor basis.
The Company is selling 6,000,000 Underwritten
Shares.
The Company has granted an option to the
Underwriters to purchase up to an additional 900,000 Option Shares.
EXHIBIT A
[Omitted]
EXHIBIT B
[Omitted]
Exhibit 5.1
January 11, 2024
Acadia Realty Trust
411 Theodore Fremd Avenue
Suite 300
Rye, New York 10580
Re: Registration
Statement on Form S-3 (File No. 333-275356)
Ladies and Gentlemen:
We have served as Maryland counsel
to Acadia Realty Trust, a Maryland real estate investment trust (the “Trust”), in connection with certain matters of Maryland
law relating to the sale and issuance of up to 6,900,000 common shares (the “Shares”) of beneficial interest, par value $0.001
per share, of the Trust (including up to 900,000 Shares which the underwriter in the offering has the option to purchase), covered by
the above-referenced Registration Statement, and all amendments related thereto (the “Registration Statement”), filed by the
Trust with the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended
(the “1933 Act”).
In connection with our representation
of the Trust, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified
to our satisfaction, of the following documents (hereinafter collectively referred to as the “Documents”):
1. The Registration Statement
and the related form of prospectus included therein in the form in which it was transmitted to the Commission under the 1933 Act;
2.
The Declaration of Trust of the Trust, as amended and supplemented (the
“Declaration of Trust”), certified by the State Department of Assessments and Taxation of Maryland (the
“SDAT”);
3. The Amended and Restated
Bylaws of the Trust, certified as of the date hereof by an officer of the Trust;
4. A
certificate of the SDAT as to the good standing of the Trust, dated as of a recent date;
5.
Resolutions adopted by the Board of Trustees of the Trust, or a duly
authorized committee thereof (the “Resolutions”), relating to, among other matters, the authorization of the
registration, sale and issuance of the Shares, certified as of the date hereof by an officer of the Trust;
Acadia Realty Trust
January 11, 2024
Page 2
6. A
certificate executed by an officer of the Trust, dated as of the date hereof; and
7. Such other documents and
matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and
qualifications stated herein.
In expressing the opinion set forth below, we have assumed
the following:
1. Each individual executing
any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.
2. Each individual executing
any of the Documents on behalf of a party (other than the Trust) is duly authorized to do so.
3. Each of the parties (other
than the Trust) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is
a signatory, and such party’s obligations set forth therein are legal, valid and binding and are enforceable in accordance with
all stated terms.
4. All Documents submitted to
us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect
relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified
or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records reviewed or relied
upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents
are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver
of any provision of any of the Documents, by action or omission of the parties or otherwise.
5. The Shares will not be issued
or transferred in violation of the restrictions on transfer and ownership contained in Article VI of the Declaration of Trust.
Based upon the foregoing, and
subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:
1. The Trust is a real estate
investment trust duly formed and existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.
Acadia Realty Trust
January 11, 2024
Page 3
2. The issuance of the Shares
has been duly authorized and, when issued and delivered by the Trust in accordance with the Resolutions and the Registration Statement
against payment of the consideration set forth therein, the Shares will be validly issued, fully paid and nonassessable.
The foregoing opinion is limited
to the laws of the State of Maryland and we do not express any opinion herein concerning federal law or any other state law. We express
no opinion as to the applicability or effect of federal or state securities laws, including the securities laws of the State of Maryland,
or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein
would be governed by the laws of any jurisdiction other than the State of Maryland, we do not express any opinion on such matter. The
opinion expressed herein is subject to the effect of any judicial decision which may permit the introduction of parol evidence to modify
the terms or the interpretation of agreements.
The opinion expressed herein
is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We
assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact
that might change the opinion expressed herein after the date hereof.
This opinion is being furnished
to you for submission to the Commission as an exhibit to the Trust’s Current Report on Form 8-K relating to the Shares (the
“Current Report”). We hereby consent to the filing of this opinion as an exhibit to the Current Report and to the use of the
name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required
by Section 7 of the 1933 Act.
|
Very truly yours, |
|
|
|
|
v3.23.4
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Acadia Realty (NYSE:AKR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Acadia Realty (NYSE:AKR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024